$3.94
0.10[2.60%]
Last update: 1:49AM Get Real Time Here
NuCana Stock (NASDAQ:NCNA), Analyst Ratings, Price Targets, Predictions
NuCana PLC has a consensus price target of $4.4, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Oppenheimer, and Truist Securities on April 1, 2024, November 21, 2023, and September 6, 2023. With an average price target of $4.67 between Oppenheimer, Oppenheimer, and Truist Securities, there's an implied 18.44% upside for NuCana PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Truist Securities
Jefferies
Cowen & Co.
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for NuCana
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | NCNA | Buy Now | NuCana | $3.94 | 1.52% | Oppenheimer | Leland Gershell | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 11/21/2023 | NCNA | Buy Now | NuCana | $3.94 | 1.52% | Oppenheimer | Leland Gershell | → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | NCNA | Buy Now | NuCana | $3.94 | 52.28% | Truist Securities | Robyn Karnauskas | → $150 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | NCNA | Buy Now | NuCana | $3.94 | 1.52% | Oppenheimer | Leland Gershell | → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 05/22/2023 | NCNA | Buy Now | NuCana | $3.94 | 1.52% | Oppenheimer | Leland Gershell | → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 09/22/2022 | NCNA | Buy Now | NuCana | $3.94 | -23.86% | Jefferies | Eun Yang | $525 → $75 | Maintains | Buy | Get Alert |
| 03/03/2022 | NCNA | Buy Now | NuCana | $3.94 | — | Cowen & Co. | Boris Peaker | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/24/2021 | NCNA | Buy Now | NuCana | $3.94 | 128.43% | HC Wainwright & Co. | Robert Burns | $250 → $225 | Maintains | Buy | Get Alert |
FAQ
What is the target price for NuCana (NCNA)?
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on April 1, 2024. The analyst firm set a price target for $4.00 expecting NCNA to rise to within 12 months (a possible 1.52% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NuCana (NCNA)?
The latest analyst rating for NuCana (NASDAQ: NCNA) was provided by Oppenheimer, and NuCana reiterated their outperform rating.
When was the last upgrade for NuCana (NCNA)?
There is no last upgrade for NuCana.
When was the last downgrade for NuCana (NCNA)?
The last downgrade for NuCana PLC happened on March 3, 2022 when Cowen & Co. changed their price target from N/A to N/A for NuCana PLC.
When is the next analyst rating going to be posted or updated for NuCana (NCNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NuCana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NuCana was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating NuCana (NCNA) correct?
While ratings are subjective and will change, the latest NuCana (NCNA) rating was a reiterated with a price target of $4.00 to $4.00. The current price NuCana (NCNA) is trading at is $3.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.